Skip to main content
NIHPA Author Manuscripts logoLink to NIHPA Author Manuscripts
. Author manuscript; available in PMC: 2020 Jun 4.
Published in final edited form as: Structure. 2019 Mar 28;27(6):1013–1021.e3. doi: 10.1016/j.str.2019.03.003

Ion and pH Sensitivity of a TMBIM Ca2+ Channel

Gongrui Guo 1,2,#, Min Xu 3,#, Yanqi Chang 4,#, Tomas Luyten 5, Bruno Seitaj 5, Wu Liu 1,2, Ping Zhu 1, Geert Bultynck 5, Lei Shi 3,*, Matthias Quick 6,7,*, Qun Liu 1,2,8,*
PMCID: PMC6560632  NIHMSID: NIHMS1523098  PMID: 30930064

Summary

The anti-apoptotic transmembrane Bax inhibitor motif (TMBIM) containing protein family regulates Ca2+ homeostasis, cell death, and diseases including cancers. The recent crystal structures of the TMBIM homolog BsYetJ reveal a conserved Asp171-Asp195 dyad that is proposed in regulating a pH-dependent Ca2+ translocation. Here we show that BsYetJ mediates Ca2+ fluxes in permeabilized mammalian cells, and its interaction with Ca2+ is sensitive to protons and other cations. We report crystal structures of BsYetJ in additional states, revealing the flexibility of the dyad in a closed state and a pore opening mechanism. Functional studies show that the dyad is responsible for both Ca2+ affinity and pH dependence. Computational simulations suggest that protonation of Asp171 weakens its interaction with Arg60, leading to an open state. Our integrated analysis provides insights into the regulation of the BsYetJ Ca2+ channel that may inform understanding of human TMBIM proteins for their roles in cell death and diseases.

Graphical Abstract

graphic file with name nihms-1523098-f0001.jpg

eTOC:

Guo et al. present structural, functional, and computational analyses on a bacterial TMBIM Ca2+ channel BsYetJ. They show that BsYetJ mediates Ca2+ flux in mammalian cells, and its Ca2+ binding is sensitive to protons and other cations. The conserved aspartyl dyad regulates Ca2+ binding, pH sensing, and the channel pore opening and closing.

Introduction

Transmembrane Bax Inhibitor Motif (TMBIM) containing proteins are a family of membrane proteins that control Ca2+ flux across membranes to maintain Ca2+ homeostasis in subcellular Ca2+ stores (Ahn et al., 2009; Rojas-Rivera and Hetz, 2015; Gamboa-Tuz et al., 2018). TMBIM proteins are highly conserved and ubiquitously expressed in both pro- and eukaryotic cells, as well as in viruses and archaea (Figure S1) (Henke et al., 2011; Chang et al., 2014). TMBIM proteins have been shown to be associated with the suppression of cell death in response to a broad spectrum of stresses in plants and intrinsic and extrinsic programmed cell death in mammals (Reimers et al., 2008; Hu et al., 2009; Henke et al., 2011; Ishikawa et al., 2011; Lisak et al., 2015). An increasing number of studies suggest that the suppression of cell death by TMBIM proteins is directly or indirectly linked to their roles in maintaining Ca2+ homeostasis (Carrara et al., 2015; Rojas-Rivera and Hetz, 2015; Lisak et al., 2016; Liu, 2017; Luganini et al., 2018).

TMBIM proteins were originally identified from phenotypic screening of anti-apoptotic human genes in yeast overexpressing Bax, a proapoptotic protein killing yeast cells (Xu and Reed, 1998). Although there are no direct interactions between Bax and TMBIM proteins, anti-apoptotic Bcl-2 family members, such as Bcl-2 and Bcl-xL, have been alluded to interact with TMBIM proteins by co-immunoprecipitation (Xu and Reed, 1998; Urresti et al., 2016). The interactions and functional overlapping of TMBIM and Bcl-2 family proteins may provide multi-layered and redundant protections of cellular survival in response to stress signals including Bax overexpression. In humans, there are six members (TMBIM1-6) localized in diverse cellular and subcellular membranes. These proteins are dysregulated in multiple cancers (Grzmil et al., 2006; Lu et al., 2015; Rojas-Rivera and Hetz, 2015; Carrara et al., 2017). TMBIM4 and 6 are upregulated in brain, breast, and prostate cancers; they are downregulated in leukemia and colorectal cancer (Carrara et al., 2017). As a contrast, TMBIM3 is upregulated in colorectal and gastric cancer, while TMBIM1 is downregulated in leukemia, breast, and sarcoma cancers (Rojas-Rivera and Hetz, 2015). In addition to their abnormal expression in cancers, TMBIM proteins have been described with additional cellular functions. TMBIM1 is upregulated in response to mechanical stress (Yoshisue et al., 2002; Shukla et al., 2011). TMBIM2 over-expression protects against transient brain ischemia (Reich et al., 2011) and increases axon growth (Merianda et al., 2013). TMBIM4 and TMBIM6 regulate cell adhesion and migration through Ca2+-dependent mechanisms (Lee et al., 2010; Saraiva et al., 2013; Carrara et al., 2015). Located in the mitochondrial inner membrane, TMBIM5 regulates mitochondrial fragmentation and cytochrome c release (Oka et al., 2008). TMBIM6 protects against acute brain injury (Krajewska et al., 2011), promotes autophagy (Sano et al., 2012) and enables immune cell survival and function (Lisak et al., 2016). TMBIM3 and TMBIM6 may interplay with each other and synergistically mediate unfolded protein response and autophagy (Rojas-Rivera et al., 2012).

Most TMBIM-mediated cellular functions relate to their core roles in Ca2+ flux and Ca2+ homeostasis (Lisak et al., 2015; Carrara et al., 2017). TMBIM6 is able to mediate the passive leak of Ca2+ from the ER, hence its classification as a Ca2+ leak channel (Kiviluoto et al., 2013; Bultynck et al., 2014). This property of TMBIM6 lowers steady-state ER Ca2+ levels in TMBIM6-overexpressing cells (Chae et al., 2004; Xu et al., 2008). Similarly TMBIM4 lowers the content of ER and Golgi Ca2+ stores and enhances store-operated Ca2+ entry (de Mattia et al., 2009; Saraiva et al., 2013; Carrara et al., 2015).

Thus, a common feature of TMBIM proteins in cells is their ability to prevent the overloading of intracellular Ca2+ stores. This feature reduces the likelihood for Ca2+ overload and excessive Ca2+ fluxes into mitochondria to occur, thereby promoting cell survival and rendering cells more resistant to cell death stimuli (Pinton et al., 2008). In TMBIM4 and 6, several critical aspartate residues were identified to establish an assumed Ca2+-permeable channel pore near its C-terminus (Bultynck et al., 2012; Carrara et al., 2015). Originally, it was proposed that TMBIM6’s basal channel function was promoted by low pH, suggesting it would act as a H+/Ca2+ exchanger (Kim et al., 2008). However, follow-up work showed that low pH is actually abrogating Ca2+ flux through the Ca2+-permeable pore (Kiviluoto et al., 2013). However, due to challenges in obtaining mammalian TMBIM structural information, the molecular determinants leading to pore opening and closing and thus the underlying Ca2+ flux properties of TMBIM proteins remained unclear (Bultynck et al., 2012; Bultynck et al., 2014; Carrara et al., 2015). This has recently changed with the determination of the structures of a bacterial homolog of TMBIM proteins from Bacillus subtilis, BsYetJ (Chang et al., 2014). These structures reveal a unique fold of 7 transmembrane helices (TM) with its second transmembrane helix (TM2) capable of opening and closing laterally within the membrane bilayer. An aspartyl dyad that is conserved among all TMBIM members (Asp171-Asp195 in BsYetJ) (Figure S1) was proposed to be a pH sensor regulating the pore dynamics and Ca2+ translocation (Chang et al., 2014).

Here we present crystal structures of BsYetJ wild-type and variants with mutations of Asp171 or Asp195. Together with functional and computational studies we show the ion- and pH-dependent modulation of BsYetJ activity and provides insights into the core mechanism of the conserved Asp171- Asp195 dyad being the structural determinant that leads to the opening of this Ca2+ leak channel.

Results

BsYetJ can mediate Ca2+ efflux from eukaryotic intracellular Ca2+ stores

We have previously solved structures of a bacterial homolog BsYetJ and demonstrated its Ca2+ flux activity in E. coli overexpressing BsYetJ and proteoliposomes with reconstituted BsYetJ (Chang et al., 2014). Sequence alignment studies revealed that the proposed pH-sensing aspartyl-dyad (Asp171- Asp195 in BsYetJ) is a conserved feature found in TMBIM proteins across all kingdoms (Chang et al., 2014). To study the functional conservation of BsYetJ in mediating Ca2+ flux in eukaryotic cells, we assessed whether purified BsYetJ protein could promote 45Ca2+ efflux from the ER of human cells, similarly to what was previously observed for synthetic peptides derived from the TMBIM6 C terminus (Bultynck et al., 2012). We performed unidirectional 45Ca2+ flux assays in permeabilized HeLa cells. After saponin-mediated permeabilization of the HeLa cells and loading the ER Ca2+ stores to steady state with 45Ca2+, we washed the cells with thapsigargin, an inhibitor of the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), and monitored the unidirectional 45Ca2+ efflux from the ER Ca2+ stores. The resulting data are plotted as Ca2+ release and 45Ca2+ content as function of time (Figures 1A, B). Notably, addition of 2.5 μM BsYetJ provoked a major increase in the 45Ca2+ release (Figure 1A), a phenomenon that was not observed in the control condition, i.e. the addition of buffer without BsYetJ. This could also be observed as a drop in the 45Ca2+ content upon addition of the BsYetJ protein (Figure 1B). There was a delay in the BsYetJ-associated response, likely related to the time needed for BsYetJ protein to incorporate into the ER membranes. Therefore, bacterial BsYetJ, when added to permeabilized human HeLa cells, may reconstitute to the membranes of intracellular Ca2+ stores, thereby functioning as Ca2+-permeable channel-like proteins that mediate Ca2+ flux across membranes.

Figure 1. Ca2+ activity of BsYetJ.

Figure 1.

(A-B) Ca2+ efflux mediated by BsYetJ. Permeabilized HeLa cells loaded to steady-state with 45Ca2+ were incubated in Ca2+-free efflux medium. 45Ca2+ release (% / 2 min) was plotted as a function of time (A) and normalized 45Ca2+ content (%) was plotted as a function of time (B). In the time period indicated by the dark square, buffer or BsYetJ (2.5 mM) was added for 2 min. Data from a typical experiment are represented as mean ± SD (n= 2; i.e. duplicate technical repeats). The graph is representative for 3 independent experiments. (C) pH dependence of 45Ca2+ binding. Binding of 10 μM 45Ca2+ (746 Ci/mmol) to 50 ng of BsYetJ was measured in assay buffer with a pH ranging from 6.0 to 8.0. Data were fit to a Gaussian model, revealing a peak at pH 7.46 ± 0.01. (D) Apparent affinity of Ca2+ binding by BsYetJ at pH 7.5. 10 μM 45Ca2+ binding was measured in the presence of increasing concentrations of non-labeled Ca2+, yielding an EC50 of 65.4 ± 0.9 μM. (E) Ion sensitivity of BsYetJ. 10 μM 45Ca2+ binding by BsYetJ was measured in the absence (−) or presence of 5 mM or 100 mM (*) of the indicated cations. Data are represented as mean ± SEM (n= 3).

Inhibition of Ca2+ binding by ions.

To further characterize the substrate specificity profile of BsYetJ, we used scintillation proximity assay (SPA)-based binding of 45Ca2+ (Quick and Javitch, 2007; Zehnpfennig et al., 2015) in the presence or absence of several physiologically relevant cations. Whereas binding measurements performed in assay buffer containing high concentrations of Na+ (100 mM) revealed virtually no Ca2+ binding, in absence of Na+, however, robust binding of 45Ca2+ was observed (Figure 1C). Ca2+ binding was pH dependent in bell-shaped fashion, with higher activity at pH 7.5 and lower activity at pH 6 and 8. This result is consistent with our Ca2+ flux assays in proteoliposomes reported previously (Chang et al., 2014). Fitting the pH dependence of 45Ca2+ binding to a Gaussian model revealed a peak at pH 7.5 (Figure 1C). It is noteworthy to mention that even though the activity at 7.5 was higher than that observed at pH 6.0, substantial activity was still detectable at the latter pH, suggesting that BsYetJ activity is regulated by pH. Measuring the isotopic dilution of 45Ca2+ bound to BsYetJ with increasing concentrations of non-labeled Ca2+ at pH 7.5 revealed a reduction of the bound 45Ca2+ by 50 % (EC50) at a concentration of 65.4 μM of CaCl2 (Figure 1D). Since Ca2+ has an ionic radius of 0.99 Å which is very close to Na+ with an ionic radius of 0.98 A, we speculated that the concentration of Na+ that reduces 45Ca2+ binding by 50% (IC50) would be comparable to the apparent affinity of Ca2+. However, Na+, K+ and Li+ inhibited 45Ca2+ binding with IC50 of 18.5±5.7 mM, 14.0 ± 3.9 mM, and 16.1 ± 6.5 mM, respectively. The inhibitory effect of the monovalent ions Na+ and K+ at physiological concentrations suggests a regulatory mechanism by these ions on the Ca2+ leak activity of BsYetJ.

To further expand the ion regulation profile of BsYetJ, we measured 45Ca2+ binding in the presence of 5 mM each of Mg2+, Mn2+, Gd3+, Yb3+, and Lu3+ by using the SPA. We found that Mg2+ and Mn2+ had no apparent inhibition of Ca2+ binding (Figure 1E), while Yb3+ and Lu3+, and most notably Gd3+, inhibited Ca2+ binding. Among these lanthanides, Gd3+ has a much stronger inhibitory potency than Yb3+ and Lu3+. Measuring the concentration dependence of Gd3+ on 45Ca2+ binding revealed an IC50 of 24.2 ± 2.8 μM. It is possible that in addition to competing with Ca2+ for binding to the proposed Ca2+ binding site, Gd3+ might bind specifically to a remote site which may induce conformational changes unfavorable of Ca2+ binding.

Alternative pH-sensor structure determined in lipidic cubic phase

To understand the delicate structure of the pH-sensing unit in a native-like lipidic environment, we crystallized wild-type BsYetJ in lipidic cubic phase (LCP) and determined its structure at 2.5 Å resolution by molecular replacement. Figure 2A shows the superposition of the BsYetJ structure crystalized in LCP (LCPBsYetJ) on its structure crystallized in the detergent pentaethylene glycol monodecyl ether (C10E5) (C10E5BsYetJ). Both structures are in a closed conformation with an RMSD of 0.64 Å. The relatively large rearrangements are the two loops connecting to TM2, consistent with the required flexibility of TM2 capable of lateral movement in the conformational transition between open and closed states (Chang et al., 2014). In addition, some side chains adopt different rotamer conformations (Figure 2A), likely due to either interactions with lipids or detergents, or lattice packing. The structure in closed conformation is featured by the proximity of residues Arg60, Asp171, and Asp195 (Figure 2B). To see structural difference of the proposed pH-sensing dyad (Asp171-Asp195) in LCPBsYetJ and C10E5BsYetJ, we superimposed the two structures based on their Cα atoms on TM7 (Figure 2C). In the LCPBsYetJ structure, the distance between the Asp171 and Asp195 carboxylates is 2.9 Å, indicating the coupling of the two carboxylates and the protonation of Asp195 as a proton donor in hydrogen bonding. This is consistent with the corresponding H-bond in the C10E5BsYetJ structure. However, surprisingly, the side chains of Asp171 and Asp195 in LCPBsYetJ deviate from their respective positions in C10E5BsYetJ. Consequently, the two H-bond distances between Arg60 and Asp171 in LCPBsYetJ are longer than these in C10E5BsYetJ. Considering that the LCPBsYetJ structure is in a native-like environment, these relative movements show structural flexibility of these three residues even in the closed state.

Figure 2. Crystal structure of BsYetJ in LCP.

Figure 2.

(A) LCPBsYetJ structure superimposed with the structure crystallized from detergent C10E5 (C10E5BsYetJ). (B) Electron densities for the aspartyl dyad pH sensor and the conformation latch Arg60. (C) Superimposition of LCPBsYetJ with C10E5BsYetJ for the aspartyl dyad and Arg60. Dash lines show distances between indicated residues, magenta for LCPBsYetJ and dark for C10E5BsYetJ.

To induce potentially more drastic changes, we attempted soaking LCPBsYetJ crystals at pH 6 and 7. However, soaked LCPBsYetJ crystals did not diffract X-rays or even disappeared. This might suggest that the crystallographic lattice (P21) is not compatible with associated conformational changes. Nevertheless, the alternative conformations of Arg60, Asp171, and Asp195 seeing in LCPBsYetJ and C10E5BsYetJ structures show a possible pH-dependent structural transition that leads to pore opening. We can imagine that decreasing pH may increase the protonation probability of Asp171, rendering a structure to be primed for Ca2+ flux.

Structure and activities of two pH sensor mutants

To further characterize the channel structurally and biochemically, we made D171E and D195E variant constructs by adding a CH2 group to the side chains of the dyad residues Asp171 and Asp195. Note these mutations retain the overall charge. In spite of crystallization of both mutants in LCP and detergent, we found that crystals that diffracted to adequate resolutions only from detergent preparations. The two mutant structures are in their open conformations even though they were crystallized at a neutral pH 7.5 (D171EBsYetJ) and 7.0 (D195EBsYetJ) (Figures 3A, B). Both mutants were crystallized in space group C2. The solved structures indicate four molecules in asymmetric unit. In each mutant structure, the four molecules have a Cα RMSD of 0.30-0.71 Å for D171EBsYetJ and 0.230.61 Å for D195EBsYetJ. Superimposition of the four molecules indicates most conformational changes involve the movement of TM5 (Figure 3B). In both structures, Arg60 is away from forming a salt bridge with Asp171 (D195EBsYetJ) or Glu171 (D171EBsYetJ). The distances between the carboxylates at positions 171 and 195 range between 2.9 and 4.6 Å, suggesting a rather unstable coupling between the two carboxylate groups, and thus incapable of locking TM2 in a closed conformation through Arg60 engagement. Upon TM2 opening, TM5 may also undergo conformational changes, more dramatically at the C-terminal side with as much as 9° twist between two TM5 helices in D171EBsYetJ (Figure 3B, left panel). Similar TM5 twists were also seen in D195EBsYetJ but to a less extent (Figure 3B, right panel).

Figure 3. Structure and activity of two pH-sensitive mutants.

Figure 3.

(A) Two views of structures of D171EBsYetJ and D195EBsYetJ. The two mutant structures were superimposed with LCPBsYetJ. Both mutant structures are open with TM2 unlocked from residue 171. (B) Superimpositions of the four molecules in crystallographic asymmetric unit indicate the flexibility of TM5 in D171EBsYetJ (left) and D195EBsYetJ (right). (C) pH-dependent Ca2+ binding by wild-type BsYetJ (■), D171EBsYetJ (♦), or D195EBsYetJ (Δ). (D) The EC50 of Ca2+ binding by wild-type (■), D171EBsYetJ (♦) or D195EBsYetJ (Δ) was determined by isotopic dilution of 10 μM 45Ca2+ with non-radiolabeled CaCl2, yielding apparent affinity constants of 64.2 ± 1.3 μM, 1.2 ± 0.1 mM, and 1.7 ± 0.3 mM, respectively. Data are represented as mean ± SEM (n=3).

To test whether the mutations to the pH-sensing dyad affect the interaction of the proteins with Ca2+, we measured 45Ca2+ binding at different pHs for BsYetJ wild-type as well as the two mutants by SPA (Figure 3C). In contrast to the bell-shaped curve observed for the wild-type, the two mutants displayed reduced Ca2+ binding and significantly different pH dependence. Interestingly, the highest activity was measured at the lowest pH tested (pH 6.0), and Ca2+ binding was progressively reduced with increasing pH. Performing isotopic dilution of 10 μM 45Ca2+ binding by BsYetJ wild-type, D171EBsYetJ, and D195EBsYetJ at pH 6.5 revealed that the EC50 of Ca2+ binding by BsYetJ (64.2 ± 1.3 μM) is virtually indistinguishable from that determined at pH 7.5 (Figure 1D). On the other hand, the EC50 for D171EBsYetJ and D195EBsYetJ determined at pH 6.5 were determined as 1.2 ± 0.1 mM and 1.7 ± 0.3 mM, respectively (Figure 3D). Therefore, both mutants have much weaker Ca2+ affinity relative to the wild-type, suggesting that Asp171 and Asp195 play a critical role in BsYetJ function, either by directly interacting with protons and/or Ca2+ or by structurally impacting the recognition of these two ions indirectly. Thus, we propose that the change of an aspartate to glutamate on the pH-sensing dyad may have disrupted the sensing mechanism, resulting in constantly open channels with reduced Ca2+ affinities.

Protonation state of Asp171 is critical for pore closing and opening

To understand the dynamics and underlying regulation mechanism in response to pH sensing and protonation, we performed extensive and comparative molecular dynamics (MD) simulations. Starting from the closed-state structure, we compared four simulation conditions, with the Asp171 or Glu171 in either deprotonated or protonated state. In the control simulations of the Asp171-deprotonated condition, the Asp171 and protonated Asp195 form a stable dyad; and Asp171 persistently forms a strong salt bridge with Arg60 (Figure 4A). In the Asp171-protonated condition, the protonation of Asp171 not only disrupted the Arg60-Asp171 salt bridge, the conformation of the Asp171-Asp195 dyad is different from the Asp171-deprotonated condition as well (Figure 4B). In the Glu171-deprotonated state, while we observed that the Arg60 formed the salt bridge with Glu171, the additional CH2 on the side chain of Glu171 resulted in a less optimal dyad with Asp195 and a slight TM2 rearrangement away from TM6 (Figure 4C). In the Glu171-protonated condition, all the interactions among Arg60, Glu171, and Asp195 are lost (Figure 4D). In both Asp171- and Glu171-protonated conditions, the absence of the salt bridge between Arg60 and Asp171/Glu171 caused TM2 to move downward and also away from TM6 (Figures 4B, D). Such movements are obviously in a direction towards the open state. Thus, the results of our MD simulations are consistent with that protonation of 171 facilitates the conformational transition from the closed to the open state.

Figure 4. Molecular dynamics simulations of the Asp171-Asp195 dyad.

Figure 4.

The results of MD simulations show that the mutation D171E and/or the protonation of the residue at this position disrupt the tight interactions among Arg60, Asp171, and Asp195, and result in a rearrangement of TM2 away from TM6. Representative frames of the simulations are shown for WT Asp171-deprotonated (A), WT Asp171-protonated (B), D171E Glu171-deprotonated (C), D171E Glu171-protonated (D). Note the Asp195 is protonated in all conditions. The interactions that are within the H-bond distance are indicated by dotted lines.

Discussion

In eukaryotes, cytosolic [Ca2+] is kept very low in the 100 nM range, which enables cells to exploit Ca2+ to encode signals with distinct spatiotemporal properties by transiently and locally increasing cytosolic [Ca2+] (Berridge et al., 2003). Ca2+ at a low concentration acts as a second messenger and drives a broad variety of cellular processes in response to extracellular stimuli, including exocytosis, contraction, metabolism, transcription, fertilization and proliferation (Berridge et al., 2003). The low cytosolic [Ca2+] is achieved by Ca2+-binding proteins such as parvalbumin and calbindin and by Ca2+-transport systems that pump Ca2+ out of organelles such as the ER via SERCA and Golgi via SPCA or that extrude Ca2+ to the extracellular environment via plasma membrane Ca2+ ATPases (PMCA) or Na+/Ca2+ exchangers (Carafoli and Krebs, 2016). Consequently, free Ca2+ concentrations in the ER compartments and the extracellular environment are in the ~500 μM and low mM range, respectively, which are about four orders of magnitude higher than in the cytosol. These stores provide the cells with plenty of Ca2+ that is available to use for signaling purposes.

However, overloaded intracellular Ca2+ stores can result in excessive Ca2+ transfer between the ER and the mitochondria, which can initiate Mitochondria Outer Membrane Permeabilization (MOMP) and subsequent cell death (Mattson and Chan, 2003; Pinton et al., 2008; Leanza et al., 2013). In fact, several oncogenes and tumor suppressors appear to exploit control over the ER Ca2+-filling state as a means to impact cellular fate (Bittremieux et al., 2016). Thus, not surprisingly, the Ca2+-flux properties of TMBIM-family members have been implicated in cell death control (Rojas-Rivera et al., 2012; Kiviluoto et al., 2013; Carrara et al., 2015). Despite their role in these central cellular functions, the molecular events that govern the activity and/or regulation of the TMBIM Ca2+ leak channels are not well understood (Sokolov et al., 2007). In the present study, our experimental data show that a bacterial TMBIM homolog BsYetJ can also lead to Ca2+ flux from ER Ca2+ stores from mammalian cells, suggesting that the Ca2+ flux activity of BsYetJ is conserved. Indeed, we previously used yeast polar lipids for BsYetJ-reconstituted Ca2+ flux assays, suggesting that BsYetJ is also capable of mediating Ca2+ flux in yeast cells (Chang et al., 2014). Interestingly, in humans, there are six known TMBIM proteins localized to different cellular and subcellular membranes (Lisak et al., 2015; Rojas-Rivera and Hetz, 2015; Liu, 2017). Our data present evidence that a bacterial TMBIM homolog can mediate Ca2+ fluxes from intracellular compartments of human cells. Moreover, it provides direct evidence that the Ca2+-flux property of TMBIM-related proteins is highly conserved from bacteria to human, indicating that the ability to mediate Ca2+ flux is an inherent property of the TMBIM family occurring already very early in evolution (Figure S1). However, it remains to be tested whether BsYetJ could suppress cell death as its mammalian relatives do.

Structurally, BsYetJ and likely the entire TMBIM family are different from canonical Ca2+ channels where there is a well-defined oligomeric pore and selectivity filter (Carrara et al., 2017). It has been hypothesized that the C-terminus of human TMBIM6 may form a re-entry loop and harbor a pore for Ca2+ flux (Xu and Reed, 1998; Bultynck et al., 2012). In the closed-state LCPBsYetJ and C10E5BsYetJ structures, the C-terminus is a transmembrane helix and is wrapped around by six other transmembrane helices. Two species-conserved residues, Asp195 and Asp171 (Figure S1), forms a hydrogen bond and we have hypothesized their roles in pH sensing and Ca2+ activity (Bultynck et al., 2014; Chang et al., 2014). In this study, we mutated either residue to a glutamate and showed that such mutation, even though retaining the overall negative charge, was defective to bind Ca2+ and lost the pH-dependent profile as the wild-type (Figures 3C, D). Our biochemical and structural data demonstrate that the two aspartate residues are important in defining a Ca2+ passage pore, which is permeable for Ca2+. It is noticed that Ca2+ affinity can be inhibited by monovalent ions Na+, K+, and Li+. So it is possible that these ions may all affect the binding of Ca2+ to the two mutants. In human TMBIM6, mutating Asp213 (equivalent to Asp195 in BsYetJ) to an arginine affected Ca2+ flux (Bultynck et al., 2012). Moreover, in contrast to wild-type TMBIM6, its D213R mutant was unable to protect cells against thapsigargin-induced cell death (Kiviluoto et al., 2013). Similarly, in human TMBIM4, mutating Asp219 (equivalent to Asp195 in BsYetJ) to an asparagine also affected the Ca2+ flux. Importantly, this D219N mutant lost its protective role in apoptosis, thus firmly established the connection of Ca2+ flux to apoptosis (Carrara et al., 2015). Learning from human relatives, mutants on Asp195 and Asp171 should help to decipher physiological roles of BsYetJ and its homologs in prokaryotes.

In our SPA-based 45Ca2+ binding assays we found that monovalent ions Na+, K+ and Li+ inhibited Ca2+ binding to BsYetJ at physiological concentrations. It is possible that monovalent cations may regulate the basal channel activity of BsYetJ. Whether BsYetJ is also leaky to these monovalent ions is unknown and will be an intriguing question for future research. Interestingly, divalent ions, Mg2+ and Mn2+ do not show apparent inhibition, suggesting that the channel is more specific to Ca2+ perhaps owing to the unique size of Ca2+. This size selection is supported by the inhibitory effects by several lanthanides (Gd3+, Yb3+, Lu3+) that are Ca2+ surrogates of similar ionic radius. Based on the interkindom- mediated functional complementation of Ca2+ flux in mammalian cells by BsYetJ, it is feasible to assume that all TMBIM proteins possess Ca2+ flux activity. Furthermore, it seems likely that TMBIM family members share an ion recognition pattern that is similar to that of BsYetJ, but this hypothesis requires experimental validation through studies targeting eukaryotic family members. In our SPA measurements performed at different pHs, we found that Ca2+ binding follows a bell-shaped curve with a maximum at around pH 7.5 (Figure 3C). At this pH, BsYetJ wild-type is much more active than the two dyad mutants, suggesting that the sensor can effectively detect environmental changes in pH, undergo protonation steps, and conduct Ca2+ flux. These observations correlate very well with recent work showing that Ca2+ flux through the C-terminal peptide corresponding to TMBIM6’s Ca2+-channel- pore domain displays a bell-shaped dependence towards pH (Kiviluoto et al., 2013).

In bacteria, the physiological roles of TMBIM-mediated Ca2+ leak remain elusive. Nevertheless, intracellular Ca2+ is key to bacterial chemotaxis, mobility, virulence, and adaptation to environment (Dominguez et al., 2015). Although there are no intracellular Ca2+ stores in bacteria, several components of the Ca2+ signaling toolkits are expressed, including Ca2+-binding proteins and Ca2+- transport systems, such as P-type ATPases, electrochemical potential driven transporters and channels (Dominguez, 2004; Shemarova and Nesterov, 2014; Dominguez et al., 2015). While basal cytosolic [Ca2+] in prokaryotes is kept low in the 100-300 nM range, cytosolic [Ca2+] can transiently rise in responses to nitrogen starvation, environmental stress, and production of metabolites (Dominguez et al., 2015). Consequently, the expression of hundreds of genes is affected transiently by the increased cytosolic [Ca2+], indicating a key role for Ca2+ signaling in the control of physiological processes in bacteria (Dominguez et al., 2015).

STAR*Methods

Contact for Reagent and Resource Sharing

Further information and reasonable requests for resources and reagents should be directed to and will be fulfilled by the Lead Contact, Qun Liu (qunliu@bnl.gov).

Experimental Model and Subject Details

Cell Culture

Adherent HeLa cells were cultured in DMEM medium (Invitrogen) at 37 °C and 5% CO2. The culture was supplemented with 10% FBS (Invitrogen). For maintenance, HeLa cells were sub-cultured twice a week and at least three passages were performed prior to experiments.

Method Details

Protein Production

Expression and purification of N-terminal truncation (Δ5BsYetJ), D195EBsYetJ, and D171EBsYetJ were performed using the previously established protocols for the wild-type BsYetJ (Chang et al., 2014). Briefly, D195EBsYetJ and D171EBsYetJ mutations were generated by using a QuikChange Site-directed mutagenesis kit. pMCSG7 plasmid harboring the wild-type YetJ gene (Chang et al., 2014) was used as template to generate the two mutations. For the D171EBsYetJ mutation, primers 5'- ttttccctttacattttgtatgagttgaaccaaatcaagcaccgcca-3' (F) and 5'- tggcggtgcttgatttggttcaactcatacaaaatgtaaagggaaaa-3' (R) were used. For the D195EBsYetJ mutation, primers 5'-ggcgttatcgctgtacctagagtttatcaacttgttcatcaac-3' (F) and 5'- gttgatgaacaagttgataaactctaggtacagcgataacgcc-3' (R) were used. Both mutations were verified by sequencing. Protein expression was conducted in Escherichia coli BL21 pLysS cells growing in Terrific Broth medium. All purification steps were performed at 4 °C. Frozen cell pellets were suspended in a suspension buffer that contains 50 mM HEPES, pH 7.8, 300 mM NaCl, and 20 mM imidazole, 5% glycerol, and 1 mM MgCl2. Cells were lysed by using an EmulsiFlex-C3 homogenizer (Avestin, Ottawa, Canada); and cell debris was removed by centrifugation at 15,000g for 30 min. Membranes were collected by centrifugation at 150,000g for 60 min and solubilized by addition of n-dodecyl β-D- maltopyranoside (DDM) to a final concentration of 1.5% (w/v) for 2 hrs. Cleaned-up supernatant was loaded to a HisTrap™ FF column (GE Healthcare, Inc.) and the protein was eluted by a linear gradient concentration of imidazole from 75 mM to 500 mM in the buffer of 50 mM HEPES, pH 7.8, 300 mM NaCl, 5% glycerol and 0.05% DDM. The affinity tag was cleaved by overnight incubation with sufficient amount of tobacco etch virus (TEV) protease and the enzyme was then removed by a second passage through the nickel column. The flow-through was concentrated and detergent was changed to n- dodecyl-N,N-dimethylamine-N-oxide (LDAO) by gel-filtration on a Superdex 200 10/300 GL column (GE Healthcare, Inc) with an elution buffer containing 25 mM Tris-HCl pH 8.0, 400 mM NaCl, 0.05% LDAO (w/v). Purified protein was concentrated to 10-13 mg/mL with an Amicon Ultra-15 centrifugal filter (Milipore, Inc).

Crystallization

For LCP crystallization, we used the N-terminal truncations (Δ5BsYetJ). To make lipidic cubic phase, we mixed 10 μL of protein (10 mg/mL) with 15 μL of monoolein (1:1.5 v/v) to get 40% hydration. Crystals were grown from the condition by mixing 50 nL of LCP with 800 nL of precipitant that contained 0.1 M Tris, pH 7.8, 5% PGA-LM (w/v), and 30% PEG 400 (v/v). The LCP crystals were harvested and cryocooled for cryogenic data collection.

For crystallization of D171EBsYetJ and D195EBsYetJ mutants, equal volumes of protein (10-12 mg/mL) in detergent LDAO were mixed with precipitants that contained 0.1 M MOPS, pH 7.5, 38% PEG 400, and 0.2 M NaCl (for D171EBsYetJ) or 0.1 M ADA, pH 7.0, 30% PEG 600 (v/v) (for D195EBsYetJ). For both conditions, only needles crystals were obtained. These needles were harvested and cryocooled for cryogenic data collection.

Structure Determination

Diffraction data were collected at National Synchrotron Light source (NSLS) beamline X25 with a Quantum 315R detector and Advanced Photon Source (APS) NE-CAT 24-ID-C beamline with a Pilatus 6M detector under a cryogenic temperature of 100 K. All data sets were indexed and integrated by XDS (Kabsch, 2010) and scaled and merged by CCP4 program AIMLESS (Winn et al., 2011). Data collection and reduction statistics for single and multi-crystal data sets are listed in Table 1.

Table 1.

Data collection and refinement statistics

Data collection LCPBsYetJ D171EBsYetJ D195EBsYetJ
Wavelength (Å) 0.979 0.979 1.1
Space group P21 C2 C2
Cell dimensions 33.86, 62.04, 47.34 218.09, 117.30, 52.41 217.33, 118.20, 51.89
a, b, c (Å)
β (°)
93.95 92.96 93.23
Solvent content (%) 44.0 65.0 65.1
Bragg spacings (Å) 37.39-2.50
(2.63-2.50)
47.15-3.10
(3.31-3.10)
39.96-3.1
(3.31-3.10)
Total reflections 46387 76248 92561
Unique reflections 6634 23721 23817
Completeness (%) 95.3 (78.4) 99.1 (99.7) 99.8 (99.9)
I/σ(I) 6.0 (2.4) 5.4 (1.1) 6.0 (1.1)
Rmeas 0.218 (0.939) 0.266 (1.429) 0.312 (2.124)
Multiplicity 7.0 (6.5) 3.2 (3.2) 3.9 (3.9)
CC1/2 97.3 (77.0) 98.1 (36.6) 98.6 (37.2)
Refinement
Resolution (Å) 2.5 3.1 3.1
No. reflections 6273 23641 23799
Rwork/Rfree 0.243/0.260 0.243/0.271 0.247/0.276
No. atoms 1624 6430 6416
  Protein 1592 6430 6416
  Water 31 - -
Average B (Å2) 39.6 61.53 68.0
Protein 39.5 61.53 68.0
Water 44.0 - -
R.m.s deviations
Bond length (Å) 0.007 0.002 0.002
Bond angle (°) 0.986 0.454 0.409

PDB code 6NQ7 6NQ8 6NQ9

Structures were determined by molecular replacement method by PHASER (Read and McCoy, 2011) with starting model of either the closed or open state (Chang et al., 2014). Specifically, for the LCP structure, we used the closed state structure at pH 8 (PDB code 4PGR) for molecular replacement; and for the two mutants, we tried both the closed (PDB code 4PGR) and the open state structures (PDB code 4PGS). The LCP crystal was crystallized in space group P21 and molecular replacement solution is performed with only one molecule in asymmetric unit. The two mutants were both crystallized in space group C2 with four molecules in an asymmetric unit. Molecular replacement with the open-state structure gave the highest Z score as reported by PHASER.

The three structures were refined by CCP4 program REFMAC5 and PHENIX (Adams et al., 2010; Murshudov et al., 2011). Model and solvent adjustment and validation were performed iteratively with COOT (Brown et al., 2015) and PHENIX (Afonine et al., 2012). For the two mutant structures, non- crystallographic symmetry was used for restraints and TLS parameters were refined to model anisotropy. The stereochemistry of refined structures was validated with PROCHECK (Laskowski et al., 1993) and MOLPROBITY (Chen et al., 2010) for quality assurance. Data statistics for refinements were listed in Table 1.

Unidirectional 45Ca2+-flux assay in HeLa cells

Unidirectional 45Ca2+ efflux assays were performed following the previously established protocols (Luyten et al., 2014). We performed the experiments in 24-well tissue culture plates of which only 12 wells were analyzed. Confluent monolayers of HeLa cells were obtained by seeding 30,000 cells per well and growing them for 7 days at 37 °C and 5% CO2 in DMEM medium. The culture medium was removed, and the cells were permeabilized in a solution containing 120 mM KCl, 30 mM imidazole-HCl, pH 6.8, 2 mM MgCl2, 1 mM Na-ATP, 1 mM K-EGTA, and 20 μg saponin ml−1. After permeabilization for 10 mins at 25 °C, Ca2+ stores were loaded for 45 min with 45Ca2+ in a solution containing 120 mM KCl, 30 mM imidazole-HCl, pH 6.8, 5 mM MgCh, 5 mM Na-ATP, 0.44 mM K-EGTA, and 150 nM free Ca2+ mixed with 45Ca2+ (with a specific activity of 0.3 MBq/mL). Then, 200 μl of efflux buffer containing 120 mM KCl, 30 mM imidazole-HCl, pH 6.8, and 1 mM K-EGTA was added and removed every 2 min. The indicated BsYetJ (2.5 mM) or buffer was added. At the end of each experiment, the 45Ca2+ remnant in the ER was determined by incubating with 200 μl of 2% (w/v) SDS solution for 30 min.

Scintillation Proximity Assay (SPA)

Binding of 45Ca2+ by BsYetJ wild-type and its mutants was measured with the SPA. For the assay 50 ng of protein was incubated with 10 μM 45Ca2+ (746 Ci/mmol) in the presence of 2.5 mg/mL YSi His tag SPA beads in 500 mM Tris/MES, with a pH ranging from pH 6.0 to 8.0, 20% glycerol (w/v), 0.1 % DDM (w/v) and 1 mM TCEP. Tris/MES was equimolarly replaced with indicated salts. The specific cpm of 45Ca2+ binding was determined by subtracting the non-proximity-based cpm, determined in the presence of 400 mM imidazole which prevents binding of the His-tagged recombinant protein to the YSi His tag SPA beads, from the total signal). Data of representative figures are shown as the mean ± S.E.M of triplicate determinations with at least three independent repeats. Non-linear regression fitting was performed in Sigma Plot 13 (Systat software), and the results are shown as mean ± S.E.M. of the fit.

Molecular Dynamics Simulations

The molecular models were all constructed starting from the closed-state structure of the wild-type YetJ (PDB ID 4PGR). MD simulations of these models were performed in the explicit water and 1-palmitoyl- 2-oleoylphosphatidylcholine (POPC) lipid bilayer environment using Desmond MD System (version 4.5; D. E. Shaw Research, New York, NY) with the CHARMM36 force field (MacKerell et al., 1998; MacKerell et al., 2004; Klauda et al., 2010; Best et al., 2012) and TIP3P water model. The system charges were neutralized, and 150 mM NaCl was added. The average size of the simulation systems was ~68000 atoms. The Protein-membrane relaxation was carried out with a protocol modified from that developed by Schrodinger, LLC. Briefly, the initial energy minimization was followed by equilibration with restraints on all protein and ligand heavy atoms in the beginning for 1 ns, then with restraints only on the protein backbone for 6 ns. For both the equilibrations and the following unrestrained production runs, we used Langevin constant pressure and temperature dynamical system (Feller et al., 1995) to maintain the pressure at 1 atm and the temperature at 310K, on an anisotropic flexible periodic cell with a constant-ratio constraint applied on the lipid bilayer in the X-Y plane.

For each condition, we collected multiple trajectories: WT Asp171-deprotonated (2 trajectories, totally 3.6 μs), WT Asp171-protonated (8 trajectories, totally 10.8 pμs), D171E Glu171-deprotonated (10 trajectories, totally 6 μs), D171E Glu171-protonated (10 trajectories, totally 6 μs). Figure 4 consists the representative frames of each condition.

Quantification and Statistical Analysis

Unidirectional flux experiments were done in duplicates with purified protein sample. SPA experiments were done in triplicates with purified protein samples.

Data and Software Availability

Data Resources

Atomic coordinates and structure factor files have been deposited in the RCSB Protein Data Bank (PDB) under the accession code 6NQ7 for wild-type LCPBsYetJ structure, 6NQ8 for D171EBsYetJ structure, and 6NQ9 for D195EBsYetJ structure.

Supplementary Material

1

Highlights:

  • BsYetJ mediates Ca2+ flux in mammalian cells

  • The Ca2+-binding activity is sensitive to protons and other cations

  • The Asp171-Asp195 dyad controls pore opening and pH-dependent Ca2+ binding

  • Protonation of Asp171 leads to an open-state structure

Acknowledgements

This project was supported by BNL LDRD 17-023 to Q.L., NIDA IRP Z1A DA000606-03 to L.S., and NIH R01 GM119396 to M.Q. Work in the lab of G.B. was supported by grants from the Research Council – KU Leuven (OT/14/101) and Research Foundation – Flanders (FWO grants G.0901.18 and W0.019.17N). We thank beamline staff at NSLS X25, NSLS-II FMX and AMX, and APS NE-CAT for their assistance in crystal screening and data collection. Part of this work was conducted at NE-CAT which is funded by NIH P30 GM124165 and S10 RR029205. This research used resources of the National Synchrotron Light source II and Advanced Photon Source, two U.S. Department of Energy Office of Science User Facilities operated under Contract No. DE-SC0012704 and DE-AC02-06CH11357, respectively.

Footnotes

Supplemental Information

Supplemental information includes one figure. Document S1. Figure S1

Declaration of Interests

The authors declare no competing interests.

Publisher's Disclaimer: This is a PDF file of an unedited manuscript that has been accepted for publication. As a service to our customers we are providing this early version of the manuscript. The manuscript will undergo copyediting, typesetting, and review of the resulting proof before it is published in its final citable form. Please note that during the production process errors may be discovered which could affect the content, and all legal disclaimers that apply to the journal pertain.

References

  1. Adams PD, Afonine PV, Bunkoczi G, Chen VB, Davis IW, Echols N, Headd JJ, Hung LW, Kapral GJ, Grosse-Kunstleve RW, et al. (2010). PHENIX: a comprehensive Python-based system for macromolecular structure solution. Acta Crystallogr D 66, 213–221. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Afonine PV, Grosse-Kunstleve RW, Echols N, Headd JJ, Moriarty NW, Mustyakimov M, Terwilliger TC, Urzhumtsev A, Zwart PH, and Adams PD (2012). Towards automated crystallographic structure refinement with phenix.refine. Acta Crystallogr D 68, 352–367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Ahn T, Yun CH, Chae HZ, Kim HR, and Chae HJ (2009). Ca2+/H+ antiporter-like activity of human recombinant Bax inhibitor-1 reconstituted into liposomes. FEBS J 276, 2285–2291. [DOI] [PubMed] [Google Scholar]
  4. Berridge MJ, Bootman MD, and Roderick HL (2003). Calcium signalling: dynamics, homeostasis and remodelling. Nat Rev Mol Cell Biol 4, 517–529. [DOI] [PubMed] [Google Scholar]
  5. Best RB, Zhu X, Shim J, Lopes PEM, Mittal J, Feig M, and MacKerell AD (2012). Optimization of the Additive CHARMM All-Atom Protein Force Field Targeting Improved Sampling of the Backbone phi, psi and Side-Chain chi(1) and chi(2) Dihedral Angles. J Chem Theory Comput 8, 3257–3273. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Bittremieux M, Parys JB, Pinton P, and Bultynck G (2016). ER functions of oncogenes and tumor suppressors: Modulators of intracellular Ca2+ signaling. Mol Cell Res 1863, 1364–1378. [DOI] [PubMed] [Google Scholar]
  7. Brown A, Long F, Nicholls RA, Toots J, Emsley P, and Murshudov G (2015). Tools for macromolecular model building and refinement into electron cryo-microscopy reconstructions. Acta Crystallogr D 71, 136–153. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bultynck G, Kiviluoto S, Henke N, Ivanova H, Schneider L, Rybalchenko V, Luyten T, Nuyts K, De Borggraeve W, and Bezprozvanny I (2012). The C terminus of Bax inhibitor-1 forms a Ca2+- permeable channel pore. J Biol Chem 287, 2544–2557. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Bultynck G, Kiviluoto S, and Methner A (2014). Bax inhibitor-1 is likely a pH-sensitive calcium leak channel, not a H+/Ca2+ exchanger. Sci Signal 7, pe22–pe22. [DOI] [PubMed] [Google Scholar]
  10. Carafoli E, and Krebs J (2016). Why Calcium? How Calcium Became the Best Communicator. J Biol Chem 291, 20849–20857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Carrara G, Parsons M, Saraiva N, and Smith GL (2017). Golgi anti-apoptotic protein: a tale of camels, calcium, channels and cancer. Open Biol 7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Carrara G, Saraiva N, Parsons M, Byrne B, Prole DL, Taylor CW, and Smith GL (2015). Golgi anti-apoptotic proteins are highly conserved ion channels that affect apoptosis and cell migration. J Biol Chem 290, 11785–11801. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chae HJ, Kim HR, Xu CY, Bailly-Maitre B, Krajewska M, Krajewski S, Banares S, Cui J, Digicaylioglu M, Ke N, et al. (2004). BI-1 regulates an apoptosis pathway linked to endoplasmic reticulum stress. Mol Cell 15, 355–366. [DOI] [PubMed] [Google Scholar]
  14. Chang Y, Bruni R, Kloss B, Assur Z, Kloppmann E, Rost B, Hendrickson WA, and Liu Q (2014). Structural basis for a pH-sensitive calcium leak across membranes. Science 344, 1131–1135. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Chen VB, Arendall WB, Headd JJ, Keedy DA, Immormino RM, Kapral GJ, Murray LW, Richardson JS, and Richardson DC (2010). MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr D 66, 12–21. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. de Mattia F, Gubser C, van Dommelen MM, Visch HJ, Distelmaier F, Postigo A, Luyten T, Parys JB, de Smedt H, Smith GL, et al. (2009). Human Golgi antiapoptotic protein modulates intracellular calcium fluxes. Mol Biol Cell 20, 3638–3645. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Dominguez DC (2004). Calcium signalling in bacteria. Mol Microbiol 54, 291–297. [DOI] [PubMed] [Google Scholar]
  18. Dominguez DC, Guragain M, and Patrauchan M (2015). Calcium binding proteins and calcium signaling in prokaryotes. Cell Calcium 57, 151–165. [DOI] [PubMed] [Google Scholar]
  19. Feller SE, Zhang YH, Pastor RW, and Brooks BR (1995). Constant-pressure molecular- dynamics simulation - the Langevin piston method. J Chem Phys l03, 4613–4621. [Google Scholar]
  20. Gamboa-Tuz SD, Pereira-Santana A, Zhao T, Schranz ME, Castano E, and Rodriguez-Zapata LC (2018). New Insights into the Phylogeny of the TMBIM Superfamily across the Three of Life: Comparative Genomics and Synteny Networks Reveal Independent Evolution of the BI and LFG Families in Plants. Mol Phylogenet Evol 126, 266–278. [DOI] [PubMed] [Google Scholar]
  21. Grzmil M, Kaulfuss S, Thelen P, Hemmerlein B, Schweyer S, Obenauer S, Kang TW, and Burfeind P (2006). Expression and functional analysis of Bax inhibitor-1 in human breast cancer cells. J Pathol 208, 340–349. [DOI] [PubMed] [Google Scholar]
  22. Henke N, Lisak DA, Schneider L, Habicht J, Pergande M, and Methner A (2011). The ancient cell death suppressor BAX inhibitor-1. Cell Calcium 50, 251–260. [DOI] [PubMed] [Google Scholar]
  23. Hu L, Smith TF, and Goldberger G (2009). LFG: a candidate apoptosis regulatory gene family. Apoptosis 14, 1255–1265. [DOI] [PubMed] [Google Scholar]
  24. Ishikawa T, Watanabe N, Nagano M, Kawai-Yamada M, and Lam E (2011). Bax inhibitor-1: a highly conserved endoplasmic reticulum-resident cell death suppressor. Cell Death Differ 18, 1271–1278. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Kabsch W (2010). XDS. Acta Crystallogr D 66, 125–132. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Kim HR, Lee GH, Ha KC, Ahn T, Moon JY, Lee BJ, Cho SG, Kim S, Seo YR, and Shin YJ (2008). Bax Inhibitor-1 Is a pH-dependent regulator of Ca2+ channel activity in the endoplasmic reticulum. J Biol Chem 283, 15946–15955. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Kiviluoto S, Luyten T, Schneider L, Lisak D, Rojas-Rivera D, Welkenhuyzen K, Missaen L, De Smedt H, Parys JB, and Hetz C (2013). Bax inhibitor-1-mediated Ca2+ leak is decreased by cytosolic acidosis. Cell Calcium 54, 186–192. [DOI] [PubMed] [Google Scholar]
  28. Klauda JB, Venable RM, Freites JA, O'Connor JW, Tobias DJ, Mondragon-Ramirez C, Vorobyov I, MacKerell AD, and Pastor RW (2010). Update of the CHARMM all-atom additive force field for lipids: validation on six lipid types. J Phys Chem B 114, 7830–7843. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Krajewska M, Xu L, Xu WJ, Krajewski S, Kress CL, Cui JK, Yang L, Irie F, Yamaguchi Y, Lipton SA, et al. (2011). Endoplasmic reticulum protein BI-1 modulates unfolded protein response signaling and protects against stroke and traumatic brain injury. Brain Research 1370, 227–237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Laskowski RA, Macarthur MW, Moss DS, and Thornton JM (1993). Procheck - a program to check the stereochemical quality of protein structures. J Appl Crystallogr 26, 283–291. [Google Scholar]
  31. Leanza L, Biasutto L, Manago A, Gulbins E, Zoratti M, and Szabo I (2013). Intracellular ion channels and cancer. Front Physiol 4, 227. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lee G-H, Ahn T, Kim D-S, Park SJ, Lee YC, Yoo WH, Jung SJ, Yang J-S, Kim S, and Muhlrad A (2010). Bax inhibitor 1 increases cell adhesion through actin polymerization: involvement of calcium and actin binding. Mol Cell Biol 30, 1800–1813. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Lisak D, Schacht T, Gawlitza A, Albrecht P, Aktas O, Koop B, Gliem M, Hofstetter HH, Zanger K, Bultynck G, et al. (2016). BAX inhibitor-1 is a Ca2+ channel critically important for immune cell function and survival. Cell Death Differ 23, 358–368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. Lisak DA, Schacht T, Enders V, Habicht J, Kiviluoto S, Schneider J, Henke N, Bultynck G, and Methner A (2015). The transmembrane Bax inhibitor motif (TMBIM) containing protein family: Tissue expression, intracellular localization and effects on the ER CA2+-filling state. Mol Cell Res 1853, 2104–2114. [DOI] [PubMed] [Google Scholar]
  35. Liu Q (2017). TMBIM-mediated Ca2+ homeostasis and cell death. Mol Cell Res 1864, 850–857. [DOI] [PMC free article] [PubMed] [Google Scholar]
  36. Lu B, Li Y, Li H, Zhang Y, Xu J, Ren L, Fu S, and Zhou Y (2015). Bax inhibitor-1 is overexpressed in non-small cell lung cancer and promotes its progression and metastasis. Int J Clin Exp Pathol 8, 1411–1418. [PMC free article] [PubMed] [Google Scholar]
  37. Luganini A, Di Nardo G, Munaron L, Gilardi G, Pla AF, and Gribaudo G (2018). Human cytomegalovirus US21 protein is a viroporin that modulates calcium homeostasis and protects cells against apoptosis. Proc Natl Acad Sci USA 115, E12370–E12377. [DOI] [PMC free article] [PubMed] [Google Scholar]
  38. Luyten T, Bultynck G, Parys JB, De Smedt H, and Missiaen L (2014). Measurement of intracellular Ca2+ release in permeabilized cells using 45Ca2+. CSH Protoc 2014, pdb. prot073189. [DOI] [PubMed] [Google Scholar]
  39. MacKerell AD, Bashford D, Bellott M, Dunbrack RL, Evanseck JD, Field MJ, Fischer S, Gao J, Guo H, Ha S, et al. (1998). All-atom empirical potential for molecular modeling and dynamics studies of proteins. J Phys Chem B 102, 3586–3616. [DOI] [PubMed] [Google Scholar]
  40. MacKerell AD, Feig M, and Brooks CL (2004). Improved treatment of the protein backbone in empirical force fields. J Amer Chem Soc 126, 698–699. [DOI] [PubMed] [Google Scholar]
  41. Mattson MP, and Chan SL (2003). Calcium orchestrates apoptosis. Nat Cell Biol 5, 1041–1043. [DOI] [PubMed] [Google Scholar]
  42. Merianda TT, Vuppalanchi D, Yoo S, Blesch A, and Twiss JL (2013). Axonal transport of neural membrane protein 35 mRNA increases axon growth. J Cell Sci 126, 90–102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Murshudov GN, Skubak P, Lebedev AA, Pannu NS, Steiner RA, Nicholls RA, Winn MD, Long F, and Vagin AA (2011). REFMAC5 for the refinement of macromolecular crystal structures. Acta Crystallogr D 67, 355–367. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Oka T, Sayano T, Tamai S, Yokota S, Kato H, Fujii G, and Mihara K (2008). Identification of a novel protein MICS1 that is involved in maintenance of mitochondrial morphology and apoptotic release of cytochrome c. Mol Biol Cell 19, 2597–2608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Pinton P, Giorgi C, Siviero R, Zecchini E, and Rizzuto R (2008). Calcium and apoptosis: ER- mitochondria Ca2+ transfer in the control of apoptosis. Oncogene 27, 6407–6418. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Quick M, and Javitch JA (2007). Monitoring the function of membrane transport proteins in detergent-solubilized form. Proc Natl Acad Sci USA 104, 3603–3608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Read RJ, and McCoy AJ (2011). Using SAD data in Phaser. Acta Crystallogr D 67, 338–344. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Reich A, Spering C, Gertz K, Harms C, Gerhardt E, Kronenberg G, Nave KA, Schwab M, Tauber SC, Drinkut A, et al. (2011). Fas/CD95 regulatory protein Faim2 is neuroprotective after transient brain ischemia. J Neurosci 31, 225–233. [DOI] [PMC free article] [PubMed] [Google Scholar]
  49. Reimers K, Choi CYU, Bucan V, and Vogt PM (2008). The Bax Inhibitor-1 (BI-1) family in apoptosis and tumorigenesis. Curr Mol Med 8, 148–156. [DOI] [PubMed] [Google Scholar]
  50. Rojas-Rivera D, Armisen R, Colombo A, Martinez G, Eguiguren AL, Diaz A, Kiviluoto S, Rodriguez D, Patron M, Rizzuto R, et al. (2012). TMBIM3/GRINA is a novel unfolded protein response (UPR) target gene that controls apoptosis through the modulation of ER calcium homeostasis. Cell Death Differ 19, 1013–1026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Rojas-Rivera D, and Hetz C (2015). TMBIM protein family: ancestral regulators of cell death. Oncogene 34, 269–280. [DOI] [PubMed] [Google Scholar]
  52. Sano R, Hou YCC, Hedvat M, Correa RG, Shu CW, Krajewska M, Diaz PW, Tamble CM, Quarato G, Gottlieb RA, et al. (2012). Endoplasmic reticulum protein BI-1 regulates Ca2+- mediated bioenergetics to promote autophagy. Gene Dev 26, 1041–1054. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Saraiva N, Prole DL, Carrara G, Johnson BF, Taylor CW, Parsons M, and Smith GL (2013). hGAAP promotes cell adhesion and migration via the stimulation of store-operated Ca2+ entry and calpain 2. J Cell Biol 202, 699–713. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Shemarova IV, and Nesterov VP (2014). Ca2+ signaling in prokaryotes. Microbiology 83, 431–437. [PubMed] [Google Scholar]
  55. Shukla S, Fujita K, Xiao Q, Liao Z, Garfield S, and Srinivasula SM (2011). A shear stress responsive gene product PP1201 protects against Fas-mediated apoptosis by reducing Fas expression on the cell surface. Apoptosis 16, 162–173. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Sokolov S, Scheuer T, and Catterall WA (2007). Gating pore current in an inherited ion channelopathy. Nature 446, 76. [DOI] [PubMed] [Google Scholar]
  57. Urresti J, Ruiz-Meana M, Coccia E, Arevalo JC, Castellano J, Fernandez-Sanz C, Galenkamp KMO, Planells-Ferrer L, Moubarak RS, Llecha-Cano N, et al. (2016). Lifeguard inhibits Fas ligand-mediated endoplasmic reticulum-calcium release mandatory for apoptosis in Type II apoptotic cells. J Biol Chem 291, 1221–1234. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Winn MD, Ballard CC, Cowtan KD, Dodson EJ, Emsley P, Evans PR, Keegan RM, Krissinel EB, Leslie AG, and McCoy A (2011). Overview of the CCP4 suite and current developments. Acta Crystallogr D 67, 235–242. [DOI] [PMC free article] [PubMed] [Google Scholar]
  59. Xu C, Xu W, Palmer AE, and Reed JC (2008). BI-1 regulates endoplasmic reticulum Ca2+ homeostasis downstream of Bcl-2 family proteins. J Biol Chem 283, 11477–11484. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Xu Q, and Reed JC (1998). Bax inhibitor-1, a mammalian apoptosis suppressor identified by functional screening in yeast. Mol Cell 1, 337–346. [DOI] [PubMed] [Google Scholar]
  61. Yoshisue H, Suzuki K, Kawabata A, Ohya T, Zhao H, Sakurada K, Taba Y, Sasaguri T, Sakai N, and Yamashita S (2002). Large scale isolation of non-uniform shear stress-responsive genes from cultured human endothelial cells through the preparation of a subtracted cDNA library. Atherosclerosis 162, 323–334. [DOI] [PubMed] [Google Scholar]
  62. Zehnpfennig B, Wiriyasermkul P, Carlson DA, and Quick M (2015). Interaction of alpha-lipoic acid with the human Na+/multivitamin transporter (hSMVT). J Biol Chem 290, 16372–16382. [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

1

Data Availability Statement

Data Resources

Atomic coordinates and structure factor files have been deposited in the RCSB Protein Data Bank (PDB) under the accession code 6NQ7 for wild-type LCPBsYetJ structure, 6NQ8 for D171EBsYetJ structure, and 6NQ9 for D195EBsYetJ structure.

RESOURCES